Copyright Reports & Markets. All rights reserved.

Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Single Coating
    • 1.3.3 Compound Coating
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Size & Forecast
    • 1.5.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity (2020-2031)
    • 1.5.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Shanghai Micro-Invasive Medical Devices
    • 2.1.1 Shanghai Micro-Invasive Medical Devices Details
    • 2.1.2 Shanghai Micro-Invasive Medical Devices Major Business
    • 2.1.3 Shanghai Micro-Invasive Medical Devices Absorbable Coronary Artery Sirolimus-Eluting Stent System Product and Services
    • 2.1.4 Shanghai Micro-Invasive Medical Devices Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Shanghai Micro-Invasive Medical Devices Recent Developments/Updates
  • 2.2 Wanrui Feihong (Beijing)
    • 2.2.1 Wanrui Feihong (Beijing) Details
    • 2.2.2 Wanrui Feihong (Beijing) Major Business
    • 2.2.3 Wanrui Feihong (Beijing) Absorbable Coronary Artery Sirolimus-Eluting Stent System Product and Services
    • 2.2.4 Wanrui Feihong (Beijing) Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Wanrui Feihong (Beijing) Recent Developments/Updates
  • 2.3 Shandong Huaan Biotechnology
    • 2.3.1 Shandong Huaan Biotechnology Details
    • 2.3.2 Shandong Huaan Biotechnology Major Business
    • 2.3.3 Shandong Huaan Biotechnology Absorbable Coronary Artery Sirolimus-Eluting Stent System Product and Services
    • 2.3.4 Shandong Huaan Biotechnology Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Shandong Huaan Biotechnology Recent Developments/Updates
  • 2.4 Jiwei Medical
    • 2.4.1 Jiwei Medical Details
    • 2.4.2 Jiwei Medical Major Business
    • 2.4.3 Jiwei Medical Absorbable Coronary Artery Sirolimus-Eluting Stent System Product and Services
    • 2.4.4 Jiwei Medical Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Jiwei Medical Recent Developments/Updates
  • 2.5 Lepu (Beijing) Medical
    • 2.5.1 Lepu (Beijing) Medical Details
    • 2.5.2 Lepu (Beijing) Medical Major Business
    • 2.5.3 Lepu (Beijing) Medical Absorbable Coronary Artery Sirolimus-Eluting Stent System Product and Services
    • 2.5.4 Lepu (Beijing) Medical Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Lepu (Beijing) Medical Recent Developments/Updates
  • 2.6 Baixinan Bio
    • 2.6.1 Baixinan Bio Details
    • 2.6.2 Baixinan Bio Major Business
    • 2.6.3 Baixinan Bio Absorbable Coronary Artery Sirolimus-Eluting Stent System Product and Services
    • 2.6.4 Baixinan Bio Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Baixinan Bio Recent Developments/Updates
  • 2.7 Micell Technologies
    • 2.7.1 Micell Technologies Details
    • 2.7.2 Micell Technologies Major Business
    • 2.7.3 Micell Technologies Absorbable Coronary Artery Sirolimus-Eluting Stent System Product and Services
    • 2.7.4 Micell Technologies Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Micell Technologies Recent Developments/Updates
  • 2.8 QualiMed
    • 2.8.1 QualiMed Details
    • 2.8.2 QualiMed Major Business
    • 2.8.3 QualiMed Absorbable Coronary Artery Sirolimus-Eluting Stent System Product and Services
    • 2.8.4 QualiMed Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 QualiMed Recent Developments/Updates
  • 2.9 Kossel
    • 2.9.1 Kossel Details
    • 2.9.2 Kossel Major Business
    • 2.9.3 Kossel Absorbable Coronary Artery Sirolimus-Eluting Stent System Product and Services
    • 2.9.4 Kossel Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Kossel Recent Developments/Updates

3 Competitive Environment: Absorbable Coronary Artery Sirolimus-Eluting Stent System by Manufacturer

  • 3.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Manufacturer (2020-2025)
  • 3.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Absorbable Coronary Artery Sirolimus-Eluting Stent System by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Absorbable Coronary Artery Sirolimus-Eluting Stent System Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Absorbable Coronary Artery Sirolimus-Eluting Stent System Manufacturer Market Share in 2024
  • 3.5 Absorbable Coronary Artery Sirolimus-Eluting Stent System Market: Overall Company Footprint Analysis
    • 3.5.1 Absorbable Coronary Artery Sirolimus-Eluting Stent System Market: Region Footprint
    • 3.5.2 Absorbable Coronary Artery Sirolimus-Eluting Stent System Market: Company Product Type Footprint
    • 3.5.3 Absorbable Coronary Artery Sirolimus-Eluting Stent System Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Size by Region
    • 4.1.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Consumption Value by Region (2020-2031)
    • 4.1.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Average Price by Region (2020-2031)
  • 4.2 North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Consumption Value (2020-2031)
  • 4.3 Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Consumption Value (2020-2031)
  • 4.5 South America Absorbable Coronary Artery Sirolimus-Eluting Stent System Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity by Type (2020-2031)
  • 5.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Consumption Value by Type (2020-2031)
  • 5.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity by Application (2020-2031)
  • 6.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Consumption Value by Application (2020-2031)
  • 6.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity by Type (2020-2031)
  • 7.2 North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity by Application (2020-2031)
  • 7.3 North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Size by Country
    • 7.3.1 North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity by Type (2020-2031)
  • 8.2 Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity by Application (2020-2031)
  • 8.3 Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Size by Country
    • 8.3.1 Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Size by Region
    • 9.3.1 Asia-Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity by Type (2020-2031)
  • 10.2 South America Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity by Application (2020-2031)
  • 10.3 South America Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Size by Country
    • 10.3.1 South America Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Absorbable Coronary Artery Sirolimus-Eluting Stent System Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Size by Country
    • 11.3.1 Middle East & Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Drivers
  • 12.2 Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Restraints
  • 12.3 Absorbable Coronary Artery Sirolimus-Eluting Stent System Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Absorbable Coronary Artery Sirolimus-Eluting Stent System and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Absorbable Coronary Artery Sirolimus-Eluting Stent System
  • 13.3 Absorbable Coronary Artery Sirolimus-Eluting Stent System Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Absorbable Coronary Artery Sirolimus-Eluting Stent System Typical Distributors
  • 14.3 Absorbable Coronary Artery Sirolimus-Eluting Stent System Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Absorbable Coronary Artery Sirolimus-Eluting Stent System market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Absorbable coronary artery sirolimus-eluting stent system is a medical device used to treat coronary artery stenosis. It combines a stent made of biodegradable materials with a drug coating containing sirolimus (also known as rapamycin). The system is designed to be implanted into the coronary artery through interventional surgery, providing support to the narrowed vessel, improving blood flow, and gradually degrading and being absorbed over time, avoiding the need for a permanent stent.
    This report is a detailed and comprehensive analysis for global Absorbable Coronary Artery Sirolimus-Eluting Stent System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Absorbable Coronary Artery Sirolimus-Eluting Stent System market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Absorbable Coronary Artery Sirolimus-Eluting Stent System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Absorbable Coronary Artery Sirolimus-Eluting Stent System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Absorbable Coronary Artery Sirolimus-Eluting Stent System market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Absorbable Coronary Artery Sirolimus-Eluting Stent System
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Absorbable Coronary Artery Sirolimus-Eluting Stent System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shanghai Micro-Invasive Medical Devices, Wanrui Feihong (Beijing), Shandong Huaan Biotechnology, Jiwei Medical, Lepu (Beijing) Medical, Baixinan Bio, Micell Technologies, QualiMed, Kossel, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Absorbable Coronary Artery Sirolimus-Eluting Stent System market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Single Coating
    Compound Coating
    Market segment by Application
    Hospital
    Clinic
    Others
    Major players covered
    Shanghai Micro-Invasive Medical Devices
    Wanrui Feihong (Beijing)
    Shandong Huaan Biotechnology
    Jiwei Medical
    Lepu (Beijing) Medical
    Baixinan Bio
    Micell Technologies
    QualiMed
    Kossel
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Absorbable Coronary Artery Sirolimus-Eluting Stent System product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Absorbable Coronary Artery Sirolimus-Eluting Stent System, with price, sales quantity, revenue, and global market share of Absorbable Coronary Artery Sirolimus-Eluting Stent System from 2020 to 2025.
    Chapter 3, the Absorbable Coronary Artery Sirolimus-Eluting Stent System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Absorbable Coronary Artery Sirolimus-Eluting Stent System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Absorbable Coronary Artery Sirolimus-Eluting Stent System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Absorbable Coronary Artery Sirolimus-Eluting Stent System.
    Chapter 14 and 15, to describe Absorbable Coronary Artery Sirolimus-Eluting Stent System sales channel, distributors, customers, research findings and conclusion.

    Buy now